Skip to content

Reduction of Myocardial Infarction by Preconditioning in Patients With Ruptured Abdominal Aortic Aneurysm

Reduction of Myocardial Infarction by Preconditioning in Patients With Ruptured Abdominal Aortic Aneurysm

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00883363
Acronym
PreconRAAA
Enrollment
200
Registered
2009-04-17
Start date
2009-04-30
Completion date
2014-12-31
Last updated
2015-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm

Keywords

precondition, ruptured abdominal aortic aneurysm, myocardial infarction

Brief summary

Preconditioning in patients treated for elective abdominal aneurysm showed that the rate of perioperative myocardial infarction could be reduced by 80 %(ARR from 27% to 5%). Precondition where performed by 10 minutes of clamping of each iliac arteries before clamping the abdominal aorta. Human studies in cardiac patients have shown promising results with precondition. Instead of clamping arteries they have all performed the procedure by inflating a blood pressure cuff above arterial pressure on a arm. The investigators want to investigate if preconditioning induced by a blood pressure cuff on a arm can reduce the perioperative rate of myocardial infarction in patients open operated for ruptured abdominal aortic aneurysm.

Interventions

PROCEDUREPrecondition

Precondition on a arm in four intervals at start of surgery for ruptured aortic aneurysm

Sponsors

Aarhus University Hospital
CollaboratorOTHER
Aarhus University Hospital Skejby
CollaboratorOTHER
Nikolaj Eldrup
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with ruptured abdominal aortic aneurysm offered surgery * Age \> 18 years

Exclusion criteria

* Technical inoperable

Design outcomes

Primary

MeasureTime frame
Reduction in myocardial infarction4 to 5 years

Secondary

MeasureTime frame
Improvement in survival Description on inflammatory response4 to 5 years

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026